05 June 2017
: Case report
Rapamycin Treatment for Benign Multicystic Peritoneal Mesothelioma: A Rare Disease with a Difficult Management
Unusual or unexpected effect of treatment, Unexpected drug reaction, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Giovanni StalloneADE, Barbara InfanteABE, Luigi CormioCDE, Luca MacariniCDE, Giuseppe GrandalianoDEDOI: 10.12659/AJCR.903548
Am J Case Rep 2017; 18:632-636
Related articles
13 Jan 2020 : Case report
Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature
Anna Sarah Erem, Shyam S. Allamaneni
DOI: 10.12659/AJCR.920487
Am J Case Rep 2020; 21:e920487
28 Jun 2020 : Laboratory Research
Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts
Ling He, Song Guo
DOI: 10.12659/MSM.922561
Med Sci Monit 2020; 26:e922561
31 Oct 2019 : Laboratory Research
Baicalin Regulates Proliferation, Apoptosis, Migration, and Invasion in Mesothelioma
Wen-Fei Xu, Feng Liu
DOI: 10.12659/MSM.919872
Med Sci Monit 2019; 25:8172-8180
07 Oct 2008
Malignant pleural mesothelioma with spinal fracture – a case report
Pregash Ellapparadja, Pradeep Madhavan
Am J Case Rep 2008; 9:408-410
30 Jun 2017 : Clinical Research
Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma
Qi Jiang, Jingjing Chen
DOI: 10.12659/MSM.904992
Med Sci Monit 2017; 23:3200-3208
11 Feb 2018 : Laboratory Research
Ursolic Acid Attenuates High Glucose-Mediated Mesangial Cell Injury by Inhibiting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Signaling Pathway
Er-Min Wang, Qiu-Ling Fan
DOI: 10.12659/MSM.907814
Med Sci Monit 2018; 24: LBR846-854
10 Mar 2018 : Clinical Research
Features and Treatment of Peritoneal Metastases from Solid Pseudopapillary Neoplasms of the Pancreas
Jianhui Wu, Xiuyun Tian
DOI: 10.12659/MSM.909363
Med Sci Monit 2018; 24: CLR1449-1456
04 Jul 2018 : Case report
Nivolumab Immunotherapy in Malignant Mesothelioma: A Case Report Highlighting a New Opportunity for Exceptional Outcomes
Riley G. Jones, Felix Karthik
DOI: 10.12659/AJCR.909584
Am J Case Rep 2018; 19:783-789
29 Nov 2016 : Laboratory Research
Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway
Wenhua Zhang, Xueqian Shao
DOI: 10.12659/MSM.898434
Med Sci Monit 2016; 22:4644-4650
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947953
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.946932
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947854
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945927
Most Viewed Current Articles
21 Jun 2024 : Case report
96,778
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,393
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
31,818
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,483
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030